Literature DB >> 6216263

Changes in human T lymphocytes after thymectomy and during senescence.

R J Van de Griend, M Carreno, R Van Doorn, C J Leupers, A Van den Ende, P Wijermans, H J Oosterhuis, A Astaldi.   

Abstract

Peripheral lymphocytes from individuals who had been thymectomized in adult life for myasthenia gravis (MG) or for other, nonimmunological reasons showed a moderate decrease in proliferative response capacity to several T-cell mitogens as compared to lymphocytes from normal individuals. The decrease of the response to mitogens and allogeneic lymphocytes was 20-30% within 5 years after thymectomy and about 50% more than 15 years after thymectomy. A comparable decrease in lymphocyte proliferative response capacity was found in healthy aged humans (68-97 years old). Analysis of T lymphocytes from both aged and thymectomized individuals with monoclonal (OKT) antibodies showed a similar pattern: the proportion of T lymphocytes binding OKT6, OKT10, or OKI1 were found. A biochemical parameter for human T-cell differentiation, the lactate dehydrogenase (LDH) isoenzyme pattern, showed a significantly lower H/M ratio in the group of elderly people compared to young individuals. Furthermore, among patients thymectomized for MG, a significant correlation was observed between the LDH isoenzyme pattern of the T lymphocytes and the proliferative response to mitogens of these cells. In contrast, in healthy thymectomized individuals the LDH isoenzyme pattern appeared to be normal. These findings indicate that, after thymectomy or involution of the thymus, at least part of the peripheral blood T lymphocytes have properties different from those of the cells of young individuals. These cells might represent immature and/or not fully differentiated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6216263     DOI: 10.1007/bf00915069

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  42 in total

1.  Age-associated involution of cellular immune function. I. Accelerated decline of mitogen reactivity of spleen cells in adult thymectomized mice.

Authors:  J A Pachciarz; P O Teague
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

2.  Characterization of two subsets of human T gamma cells.

Authors:  R J van de Griend; I ten Berge; H J Tanke; D Roos; P T Schellekens; C J Melief; W P Zeijlemaker; A Astaldi
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

3.  Reduced T-lymphocyte cell reactivity as a function of human aging.

Authors:  J P Antel; J J Oger; E Dropcho; D P Richman; H H Kuo; B G Arnason
Journal:  Cell Immunol       Date:  1980-08-15       Impact factor: 4.868

4.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  Cooperative effects in mitogen- and antigen-induced responses of human peripheral blood lymphocyte subpopulations.

Authors:  M H van Oers; J Pinkster; W P Zeijlemaker
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

6.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Immunologic studies of aging. V. Impaired proliferation of PHA responsive human lymphocytes in culture.

Authors:  J M Hefton; G J Darlington; B A Casazza; M E Weksler
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

8.  Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of aging normal humans and patients with Down's syndrome.

Authors:  C F Tam; R L Walford
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

9.  Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.

Authors:  S Berrih; C Gaud; M A Bach; H Le Brigand; J P Binet; J F Bach
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

10.  Immunological studies of Aging. III. Cytokinetic basis for the impaired response of lymphocytes from aged humans to plant lectins.

Authors:  B Inkeles; J B Innes; M M Kuntz; A S Kadish; M E Weksler
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  5 in total

1.  Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

Authors:  J B Kuks; P C Limburg; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

2.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

3.  Lymphocyte populations in patients with myasthenia gravis. Influence of thymectomy and immunosuppressive drugs.

Authors:  G Ippoliti; G Piccolo; M Lombardi; G Carnevale Maffé; V Cosi; P Pinelli
Journal:  Ital J Neurol Sci       Date:  1982-12

4.  Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.

Authors:  A Melms; G Malcherek; U Gern; N Sommer; R Weissert; H Wiethölter; H J Bühring
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

5.  Subpopulations of mononuclear cells in ageing: expansion of the null cell compartment and decrease in the number of T and B cells in human blood.

Authors:  G J Ligthart; H R Schuit; W Hijmans
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.